Patient Care Awareness Drug Development
Retinitis pigmentosa (RP) can be described as an umbrella term, says Marc Mathias, MD, associate professor of ophthalmology and retina specialist at the Sue Anschutz-Rodgers Eye Center.
Daniel Ozzello, MD, assistant professor of ophthalmology at the University of Colorado School of Medicine, sometimes compares treating thyroid eye disease, an autoimmune disease that affects muscles and tissue behind the eye, to a flood.
Patient Care Drug Development Retina rare disease
Thirteen-year-old Grace Hoyt received potentially the best birthday gift ever this month when pediatric ophthalmologists at the University of Colorado School of Medicine and Children’s Hospital Colorado administered the first treatment designed specifically to slow her vision loss associated with posterior column ataxia with retinitis pigmentosa (PCARP), a rare genetic condition that affects vision and the nervous system.
UCHealth
April 16, 2024
According to Naresh Mandava, MD, chair of the Department of Ophthalmology at the University of Colorado School of Medicine, the West Nile virus is a neurotrophic virus which means it primarily affects the nervous system. For patients like Sonny Hutchison with immunosuppressed systems, it can lead to temporary or — in rare instances — permanent vision problems.
Denver 7
April 05, 2024
Department of Ophthalmology resident Dallin Milner, MD, explains the perils of looking directly at the sun during a partial solar eclipse and how doing so can cause permanent eye damage.
Pueblo Chieftan
March 31, 2024
Sue Anschutz-Rodgers Eye Center specialists Niranjan Manoharan, MD, and Marc Mathias, MD, offer tips for safely viewing the eclipse and explain how retina tissue can be damaged — and will not regenerate, leading to permanent vision loss — if a person looks directly at the sun for too long.
Optometry Advisor
March 28, 2024
Optometrist Kaleb Abbott, OD, MS, FAAO, assistant professor of ophthalmology, writes that dry eye in glaucoma has created a conundrum for clinicians who attempt to manage their patients’ intraocular pressure (IOP) while simultaneously limiting ocular surface disease.
Kara Mason
